MENU
SWOBY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Swedish Orphan Biovitrum AB (SWOBY) Ownership - Who owns Swedish Orphan Biovitrum AB?

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology... Show more

Profile

Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1831
Web
https://www.sobi.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
9.83B
P/E Ratio
21.01
Total Cash
1.06B
Projected Growth
1.73
Total Debt
12.81B
Revenue
26.97B
Risk (Beta)
N/A
Dividend Yield
0.03
Total Cash/Share
1.54
Total Debt/Equity
N/A
Revenue/Share
4.05 USD as % of share price

Fundamentals

SWOBY
Capitalization
9.83B
P/E Ratio
21.01
Risk (Beta)
N/A
Dividend Yield
0.03
Total Cash
1.06B
Total Cash/Share
1.54
Total Debt
12.8B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.73
Revenue/Share (as % of the share price)
4.05%
Revenue
27B
ROE
N/A
Book Value
39.1B
P/B Ratio
2.34
Cash Flow
N/A
Earnings
6.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
195M
Current Ratio
1.00
Current Revenue Per Employee
3187919.50
Dividends Per Share - Security
0.00
EBITDA
9.77B
Float
N/A
Float - Current
N/A
Gross Income Margin
76.91
Revenue To Assets
6.16
Shares Held By Institutions
N/A
Shares Outstanding - Current
689M
Total Liabilities
29.7B
Total Volume MTD
N/A
Value
1
Gain YTD
8.235
View a ticker or compare two or three
SWOBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1831
Web
https://www.sobi.com